Pancreatic Cancer Research

ResearcherUniversity of the WitwatersrandActive in the last 2 years

Martin Smith

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3470-7576; OpenAlex author ID A5102967106. Sources: OpenAlex.

Their work

Papers
12 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
9
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 3 papers · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: 3 papers

Papers 12

  1. The combination ofSPP1knockdown and gemcitabine treatment enhances apoptosis and reduces invasiveness of pancreatic cancer cells Co-author DOI 10.1101/2024.05.05.24306611↗
  2. Comparative immune profiling of pancreatic ductal adenocarcinoma progression among South African patients. Co-author DOI 10.1186/s12885-024-12595-x↗
  3. Inhibition of the Complement Pathway Induces Cellular Proliferation and Migration in Pancreatic Ductal Adenocarcinoma Co-author DOI 10.23812/j.biol.regul.homeost.agents.20243802.94↗
  4. Pancreatic ductal adenocarcinoma: Prognostic indicators of advanced disease. Last author DOI 10.1371/journal.pone.0262439↗
  5. Targeting Growth Factor Signaling Pathways in Pancreatic Cancer: Towards Inhibiting Chemoresistance. Co-author DOI 10.3389/fonc.2021.683788↗
  6. Serum Metabolomic and Lipoprotein Profiling of Pancreatic Ductal Adenocarcinoma Patients of African Ancestry. Co-author DOI 10.3390/metabo11100663↗
  7. Immunotherapeutic strategies in pancreatic ductal adenocarcinoma (PDAC): current perspectives and future prospects. Co-author DOI 10.1007/s11033-020-05648-4↗
  8. SWATH-MS based proteomic profiling of pancreatic ductal adenocarcinoma tumours reveals the interplay between the extracellular matrix and related intracellular… Co-author DOI 10.1371/journal.pone.0240453↗
  9. Increased expression of plakoglobin is associated with upregulated MAPK and PI3K/AKT signalling pathways in early resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/ol.2020.11473↗
  10. Inflammatory cytokines and combined biomarker panels in pancreatic ductal adenocarcinoma: Enhancing diagnostic accuracy. Last author DOI 10.1371/journal.pone.0221169↗
  11. Inflammatory cytokines and angiogenic factors as potential biomarkers in South African pancreatic ductal adenocarcinoma patients: A preliminary report. Co-author DOI 10.1016/j.pan.2017.03.003↗
  12. Cytokines as Biomarkers of Pancreatic Ductal Adenocarcinoma: A Systematic Review. Co-author DOI 10.1371/journal.pone.0154016↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Geoffrey Patrick Candy · 8 shared papers, 2020–2024 · strength 1.33
  2. Ekene Emmanuel Nweke · 8 shared papers, 2020–2024 · strength 1.33
  3. Zanele Nsingwane · 3 shared papers, 2020–2024 · strength 0.57
  4. Yandiswa Yolanda Yako · 4 shared papers, 2016–2022 · strength 0.51
  5. Deirdré Kruger · 4 shared papers, 2016–2022 · strength 0.51
  6. Ntombikayise Xelwa · 2 shared papers, 2021–2024 · strength 0.39
  7. Nnenna Elebo · 2 shared papers, 2021–2024 · strength 0.33
  8. Martin Brand · 3 shared papers, 2016–2020 · strength 0.32
  9. Pascaline Fru · 1 shared paper, 2024 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.